ATG7 and neoplasm: Although our planned assessment of mammary cancer was not possible due to early-onset neurodegeneration, the results still predict that Atg7 ablation may impair the fitness and survival of Palb2 mutant cancer cells, thereby delaying or preventing tumor development.